Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -58%

Megatrend and thematic drivers
Megatrends include Artificial Intelligence, and Crypto & Blockchain. Themes include AI for Blockchain Applications, and Decentralized AI Infrastructure.

Weak multi-year price returns
2Y Excs Rtn is -86%, 3Y Excs Rtn is -121%

Very low revenue
Rev LTMTotal Revenue or Sales, Last Twelve Months is 0

Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -15 Mil

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -195%

Key risks
AIXC key risks include [1] its profitability challenges and "FAIR" financial health score, Show more.

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -58%
1 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, and Crypto & Blockchain. Themes include AI for Blockchain Applications, and Decentralized AI Infrastructure.
2 Weak multi-year price returns
2Y Excs Rtn is -86%, 3Y Excs Rtn is -121%
3 Very low revenue
Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
4 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -15 Mil
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -195%
6 Key risks
AIXC key risks include [1] its profitability challenges and "FAIR" financial health score, Show more.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 6/12/2026

AIxCrypto (AIXC) stock has gained about 20% since 2/28/2026 because of the following key factors:

1. Strategic Shift and Full Commitment to AI and Blockchain: AIxCrypto underwent a strategic transformation in September 2025, rebranding and explicitly pivoting its business focus from biotechnology to an ecosystem integrating artificial intelligence and blockchain technology. This commitment was further solidified in May 2026 with the announcement to discontinue and wind down its legacy biotechnology business, demonstrating a clear company-specific directional shift.

2. Positive Operational Progress in Fiscal Q1 2026: During fiscal Q1 2026 (ended March 31, 2026), AIxCrypto reported significant advancement in its product pipeline. Key progress included the initiation of an Embodied AI (EAI) Data Collaboration Project with Faraday Future, completion of initial infrastructure and commercial design for its Agentir AI Agent Arena platform, and refinement of its Real World Asset (RWA) equity tokenization strategy. Furthermore, the AIxC Hub, launched in January 2026, surpassed 5,835,615 registered wallets and 1,392,427 daily active participants as of March 16, 2026, showcasing strong company-specific product development and adoption.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 22.8% change in AIXC stock from 2/28/2026 to 6/13/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)22820266132026Change
Stock Price ($)1.141.4022.8%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)18-91.9%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2026 to 6/13/2026
ReturnCorrelation
AIXC21.9% 
Market (SPY)8.4%44.0%
Sector (XLK)33.3%45.1%

Fundamental Drivers

The -46.2% change in AIXC stock from 11/30/2025 to 6/13/2026 was primarily driven by a -91.9% change in the company's Shares Outstanding (Mil).
(LTM values as of)113020256132026Change
Stock Price ($)2.601.40-46.2%
Change Contribution By: 
Total Revenues ($ Mil)000.0%
P/S Multiple0.0%
Shares Outstanding (Mil)18-91.9%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

11/30/2025 to 6/13/2026
ReturnCorrelation
AIXC-46.5% 
Market (SPY)9.2%36.4%
Sector (XLK)29.5%39.3%

Fundamental Drivers

null
null

Market Drivers

5/31/2025 to 6/13/2026
ReturnCorrelation
AIXC  
Market (SPY)27.3%35.7%
Sector (XLK)61.0%39.3%

Fundamental Drivers

null
null

Market Drivers

5/31/2023 to 6/13/2026
ReturnCorrelation
AIXC  
Market (SPY)84.5%35.7%
Sector (XLK)129.7%39.3%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
AIXC Return-----11%-44%-51%
Peers Return39%-85%360%3%21%68%105%
S&P 500 Return27%-19%24%23%16%8%97%

Monthly Win Rates [3]
AIXC Win Rate----0%50% 
Peers Win Rate40%33%75%45%63%50% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
AIXC Max Drawdown------65% 
Peers Max Drawdown-71%-88%-54%-58%-56%-40% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: MARA, RIOT, CLSK, COIN, HUT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/12/2026 (YTD)

How Low Can It Go

AIXC has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

EventXLKS&P 500
2025 US Tariff Shock
  % Loss-25.7%-18.8%
  % Gain to Breakeven34.5%23.1%
  Time to Breakeven65 days79 days
2024 Yen Carry Trade Unwind
  % Loss-17.0%-7.8%
  % Gain to Breakeven20.4%8.5%
  Time to Breakeven92 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-10.0%-9.5%
  % Gain to Breakeven11.2%10.5%
  Time to Breakeven15 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-33.1%-24.5%
  % Gain to Breakeven49.5%32.4%
  Time to Breakeven246 days427 days
2020 COVID-19 Crash
  % Loss-31.2%-33.7%
  % Gain to Breakeven45.2%50.9%
  Time to Breakeven78 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-23.8%-19.2%
  % Gain to Breakeven31.2%23.8%
  Time to Breakeven100 days105 days

Compare to MARA, RIOT, CLSK, COIN, HUT

In The Past

State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

AIXC has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.

EventXLKS&P 500
2025 US Tariff Shock
  % Loss-25.7%-18.8%
  % Gain to Breakeven34.5%23.1%
  Time to Breakeven65 days79 days
2022 Inflation Shock & Fed Tightening
  % Loss-33.1%-24.5%
  % Gain to Breakeven49.5%32.4%
  Time to Breakeven246 days427 days
2020 COVID-19 Crash
  % Loss-31.2%-33.7%
  % Gain to Breakeven45.2%50.9%
  Time to Breakeven78 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-23.8%-19.2%
  % Gain to Breakeven31.2%23.8%
  Time to Breakeven100 days105 days
2008-2009 Global Financial Crisis
  % Loss-51.5%-53.4%
  % Gain to Breakeven106.2%114.4%
  Time to Breakeven797 days1085 days

Compare to MARA, RIOT, CLSK, COIN, HUT

In The Past

State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About AIxCrypto (AIXC)

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Major Suppliers for AIxCrypto (AIXC)

  • Bio-Rad Laboratories, Inc. (NYSE: BIO)

AI Analysis | Feedback

null

AI Analysis | Feedback

The key risks to AIxCrypto Holdings, Inc. (AIXC) are primarily related to its significant strategic shift from biotechnology to an AI and Web3 focused business, alongside the inherent challenges of operating in these nascent and volatile sectors.

  1. Execution Risk of Strategic Transformation and Competition in New Markets: AIxCrypto has undergone a substantial pivot from being Qualigen Therapeutics, a biotechnology company, to an entity focused on AI, crypto assets, and blockchain technology. This radical change in business model carries significant execution risk, as success requires navigating new, highly competitive, and rapidly evolving industries with different operational demands and expertise. Despite this shift, the company still maintains an early-clinical-stage therapeutic program (QN-302) and a preclinical Pan-RAS program, creating a dual focus that could dilute resources and attention.
  2. Regulatory and Legal Risks in AI and Web3/Crypto: The artificial intelligence, cryptocurrency, and Web3 sectors are subject to uncertain and evolving regulatory landscapes across various jurisdictions. AIxCrypto's business model, which involves crypto asset treasuries, Web3 ecosystem development, and real-world asset (RWA) tokenization, exposes it to significant regulatory and legal compliance challenges. Changes in regulations or adverse legal interpretations could severely impact its operations, product offerings, and financial viability.
  3. Market Volatility and Adoption Challenges in Crypto Assets and Web3: AIxCrypto's strategy is heavily reliant on its C10 Cryptocurrency Asset Treasury, which invests in a basket of top cryptocurrencies, and its broader Web3 ecosystem development. The cryptocurrency market is known for extreme price volatility, which can lead to significant fluctuations in asset values and directly affect the company's financial performance. Furthermore, the widespread adoption of Web3 technologies and AI-powered crypto solutions is still in its early stages and subject to technological, market acceptance, and competitive pressures, posing a risk to the growth and profitability of AIxCrypto's core offerings.

AI Analysis | Feedback

The primary emerging threat for Qualigen Therapeutics (the company described in the background for AIXC) stems from the rapid and transformative advancements in the field of oncology treatments. The development of novel therapeutic modalities such as highly effective immunotherapies (e.g., CAR-T cell therapies, bispecific antibodies), gene therapies, and personalized mRNA-based cancer vaccines could fundamentally alter the standard of care for the types of cancers Qualigen's pipeline drugs (like QN-302, QN-247, and RAS-F) aim to treat. If these advanced therapies continue to demonstrate superior efficacy, improved safety profiles, or broader applicability in clinical trials, they could pose a significant threat by rendering Qualigen's small molecule and nanoparticle-based drug candidates less competitive or potentially obsolete before they reach market. This mirrors historical disruptions where new technologies or approaches fundamentally shifted market dynamics, akin to how the iPhone redefined the mobile phone market.

AI Analysis | Feedback

AIxCrypto Holdings, Inc. (AIXC), formerly known as Qualigen Therapeutics, Inc., has strategically transitioned its focus from biotechnology to an ecosystem integrating Artificial Intelligence (AI), crypto assets, and blockchain technology, bridging Web2 and Web3 environments. The addressable markets for AIxCrypto's current main products and services are substantial and globally expanding. The key addressable markets for AIxCrypto's offerings include: * AI-Powered Crypto Trading Agents and Platforms: The global AI crypto trading bot market was valued at approximately $40.8 billion in 2024 and is projected to reach an estimated $985.2 billion by 2034, demonstrating a compound annual growth rate (CAGR) of 37.2%. Similarly, the global AI trading platform market, which was valued at $11.26 billion in 2024, is anticipated to grow to about $69.95 billion by 2034, with a CAGR of 20.04% from 2025 to 2034. In the U.S. specifically, the AI trading platform market size was $3.21 billion in 2024 and is expected to reach around $20.33 billion by 2034. The broader global AI agents market, encompassing intelligent agents capable of autonomous task execution, was estimated at $7.63 billion in 2025 and is projected to grow to $182.97 billion by 2033, with a CAGR of 49.6% from 2026 to 2033. Another report projects the AI Agents market to grow from $7.84 billion in 2025 to $52.62 billion by 2030, at a CAGR of 46.3%. * Real World Asset (RWA) Tokenization and Ecosystem Development: The global tokenized asset market has reached $340 billion as of March 2026, with stablecoins and tokenized funds driving growth. The market for non-stablecoin tokenized assets (RWAs) is approximately $26.5 billion globally as of March 2026. Experts predict that the total market value of tokenized assets will exceed $10 trillion by 2030 globally, representing a significant increase from current values. Another projection indicates that $16-30 trillion of real-world assets will be tokenized by 2030 worldwide. The tokenized real-world assets market is specifically projected to increase from $255.84 billion in 2025 to $418.57 billion in 2026, with an impressive CAGR of 63.6%, and is expected to reach $3016.29 billion by 2030 globally. Tokenized real estate, a component of RWAs, currently holds a market value just over $600 million globally. * AI-Driven Crypto Asset Management: The global crypto asset management market was valued at $0.67 billion in 2020 and is projected to reach $9.36 billion by 2030, growing at a CAGR of 30.2% from 2021 to 2030. More recent estimates place the global market size at $1.57 billion in 2025, with a projection to grow to $11.74 billion by 2034 at a CAGR of 25.06%. Another report values the global crypto asset management market at $1.35 billion in 2024, expecting it to reach $8.26 billion by 2033 with a CAGR of 22.3% from 2026 to 2033. * Web3 Ecosystems and Platforms: The global Web 3.0 blockchain market generated $2.25 billion in revenue in 2023 and is expected to reach $33.53 billion by 2030, growing at a CAGR of 47.1% from 2024 to 2030. Another estimate indicates the global Web 3.0 blockchain market size was $3.81 billion in 2025 and is projected to grow to $52.64 billion by 2034, with a CAGR of 33.89%. The overall Web3 market was valued at $3.47 billion in 2025 and is estimated to reach $29.97 billion by 2031, at a CAGR of 43.21%. The global Web 3.0 market is also projected to reach $10.8 billion in 2025 and $339.1 billion by 2034, with a CAGR of 46.6%. North America held a significant share of 43.2% of the global Web 3.0 market revenue in 2025, with the U.S. Web 3.0 market projected to reach $4.0 billion in 2025.

AI Analysis | Feedback

null

AI Analysis | Feedback

AIxCrypto Holdings, Inc. (AIXC), formerly Qualigen Therapeutics, Inc., has made several capital allocation decisions over the last 3-5 years as it transitioned from a biotechnology company to one focused on AI and Web3 technologies.

Share Issuance

  • The company engaged in private placements, including a $4.5 million private placement of Series A-3 Preferred Stock to regain Nasdaq compliance.
  • Qualigen Therapeutics completed a significant $41 million PIPE (Private Investment in Public Equity) transaction led by Faraday Future Intelligent Electric Inc., which resulted in Faraday Future becoming the majority beneficial owner.

Inbound Investments

  • A $41 million PIPE transaction from Faraday Future Intelligent Electric Inc. provided a substantial investment, leading to Faraday Future becoming the controlling and majority shareholder.

Outbound Investments

  • AIxCrypto plans to purchase $5 million worth of Faraday Future (FFAI) shares through an independent third party as its first tokenized stock project.
  • The company launched AIxC Labs with the intent to invest in AI and Web3 projects, aiming to complete two to three strategic investments by 2026.

Latest Trefis Analyses

TitleDate
0DASHBOARDS 
1AIxCrypto Earnings Notes12/16/2025
Title
0ARTICLES

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

AIXCMARARIOTCLSKCOINHUTMedian
NameAIxCryptoMARA Riot Pla.Cleanspa.Coinbase.Hut 8  
Mkt Price1.4014.0926.6416.57159.88119.0021.61
Mkt Cap0.05.49.34.442.313.27.3
Rev LTM08686537406,560284697
Op Inc LTM-15-907-389-268730-139-203
FCF LTM-10-1,283-1,273-1,0721,756-814-943
FCF 3Y Avg-9-901-1,116-9151,958-424-662
CFO LTM-10-835-634-5261,756-133-329
CFO 3Y Avg-8-650-337-3401,974-87-212

Growth & Margins

AIXCMARARIOTCLSKCOINHUTMedian
NameAIxCryptoMARA Riot Pla.Cleanspa.Coinbase.Hut 8  
Rev Chg LTM-23.1%42.4%37.7%-5.8%114.6%37.7%
Rev Chg 3Y Avg-130.6%38.6%87.9%37.1%48.6%48.6%
Rev Chg Q--18.4%3.6%-24.9%-30.5%225.5%-18.4%
QoQ Delta Rev Chg LTM--4.3%0.9%-5.8%-8.7%20.9%-4.3%
Op Inc Chg LTM-109.6%-62.0%-9.7%-186.3%-68.3%-99.3%-83.8%
Op Inc Chg 3Y Avg-17.8%-101.0%-38.3%-68.0%111.3%-368.0%-53.1%
Op Mgn LTM--104.5%-59.5%-36.2%11.1%-49.0%-49.0%
Op Mgn 3Y Avg--73.0%-74.5%-25.5%19.9%-36.4%-36.4%
QoQ Delta Op Mgn LTM--13.8%-6.5%-14.9%-9.2%-7.6%-9.2%
CFO/Rev LTM--96.2%-97.0%-71.1%26.8%-46.6%-71.1%
CFO/Rev 3Y Avg--90.9%-62.2%-61.2%31.1%-49.8%-61.2%
FCF/Rev LTM--147.8%-194.8%-144.9%26.8%-286.4%-147.8%
FCF/Rev 3Y Avg--122.8%-243.1%-176.8%30.7%-213.3%-176.8%

Valuation

AIXCMARARIOTCLSKCOINHUTMedian
NameAIxCryptoMARA Riot Pla.Cleanspa.Coinbase.Hut 8  
Mkt Cap0.05.49.34.442.313.27.3
P/S-6.214.26.06.546.56.5
P/Op Inc-0.7-5.9-23.8-16.658.0-94.9-11.2
P/EBIT-0.6-2.7-11.0-9.039.8-31.8-5.9
P/E-0.5-2.6-10.7-8.952.9-42.3-5.7
P/CFO-1.1-6.4-14.6-8.424.1-99.7-7.4
Total Yield-190.5%-38.1%-9.4%-11.3%1.9%-2.4%-10.4%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg--24.8%-37.0%-40.7%4.3%-18.3%-24.8%
D/E0.00.50.10.40.20.00.1
Net D/E-0.60.40.10.2-0.10.00.0

Returns

AIXCMARARIOTCLSKCOINHUTMedian
NameAIxCryptoMARA Riot Pla.Cleanspa.Coinbase.Hut 8  
1M Rtn3.7%6.0%8.2%18.5%-24.6%8.8%7.1%
3M Rtn22.8%51.2%89.7%69.8%-18.2%146.3%60.5%
6M Rtn-44.2%22.3%74.1%18.1%-40.2%188.1%20.2%
12M Rtn-46.8%-6.3%174.1%78.2%-34.1%580.8%35.9%
3Y Rtn-46.8%45.4%162.5%327.1%196.6%1,032.3%179.5%
1M Excs Rtn4.7%10.7%7.1%24.8%-20.6%10.0%8.6%
3M Excs Rtn10.7%39.1%77.7%57.7%-30.3%134.2%48.4%
6M Excs Rtn-52.8%10.3%63.2%6.1%-49.8%150.6%8.2%
12M Excs Rtn-70.3%-37.2%129.1%42.7%-59.6%519.1%2.7%
3Y Excs Rtn-121.4%-26.7%81.2%249.2%126.0%958.0%103.6%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil2023202220212020
Single Segment0   
License revenue 01 
Net product sales 556
Total0566


Net Income by Segment
$ Mil2025
Development and commercialization of Artificial Intelligence (AI)-enabled technology products and-17
Total-17


Assets by Segment
$ Mil202420232022
Development and commercialization of Artificial Intelligence (AI)-enabled technology products and5  
Single Segment 219
Total5219


Short Interest

Short Interest: As Of Date5292026
Short Interest: Shares Quantity0.1 Mil
Short Interest: % Change Since 515202639.1%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest2.1 days
Basic Shares Quantity7.7 Mil
Short % of Basic Shares1.4%

Earnings Returns History

Updated 6/13/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/12/20262.7%-6.5%-0.4%
3/27/20260.0%19.1%28.7%
SUMMARY STATS   
# Positive211
# Negative011
Median Positive1.3%19.1%28.7%
Median Negative -6.5%-0.4%
Max Positive2.7%19.1%28.7%
Max Negative -6.5%-0.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/11/202610-Q
12/31/202503/30/202610-K
09/30/202511/14/202510-Q
06/30/202508/14/202510-Q
03/31/202507/21/202510-Q
12/31/202406/30/202510-K
09/30/202411/14/202410-Q
06/30/202408/14/202410-Q
03/31/202407/02/202410-Q
12/31/202304/08/202410-K
09/30/202311/14/202310-Q
06/30/202308/14/202310-Q
03/31/202305/15/202310-Q
12/31/202205/02/202310-K
09/30/202211/14/202210-Q
06/30/202208/15/202210-Q
Core Cache Last Updated: 6/13/2026